u/divockoriginal · 2101d agono track record yet
$ATOS Breast cancer study produces substantially positive results 📈
Atossa Therapeutics reported substantially positive Phase 2 results for Endoxifen in breast cancer, with the trial halted early due to success. The poster expects near-term upside following a company conference, viewing early dips as a buying opportunity.
At post $42.00Now $2.33-94.5% since postedas of Nov 3, 4:45 PM ET
1d+16.1%
3d+38.9%
1w+33.6%
1m-23.6%
3m-11.4%
6m+6.8%
1y-53.6%